查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
钙通道阻滞剂市场与 COVID-19 影响分析，按药物类别、按应用、按分销渠道、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1339877

钙通道阻滞剂市场与 COVID-19 影响分析，按药物类别、按应用、按分销渠道、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Calcium Channel Blockers Market with COVID-19 Impact Analysis, By Drug Class, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 308 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年钙通道阻滞剂市场规模为 140.051 亿美元，2023 年至 2030 年復合年增长率为 6.1%。

钙通道阻滞剂市场-市场动态：

  • 心血管疾病患病率的上升以及对焦虑症或双相情感障碍患者的援助的增加预计将推动预测期内的增长。
  • 人们生活方式的改变导致心血管疾病患病率不断上升，可能会推动钙通道阻滞剂市场的增长。由于这些疾病会影响心臟或血管并降低心力衰竭和中风的风险，因此使用钙通道阻滞剂。此外，与心脏病相关的主要原因是高血压，通常称为血压升高。钙拮抗剂治疗该适应症的有效性已得到充分证明。反过来，该市场对改善心血管疾病管理的需求也在稳步增长。然而，钙通道阻滞剂的副作用，包括头痛、便秘和水肿，预计将阻碍全球钙通道阻滞剂市场的需求。此外，钙通道阻滞剂可能对一小部分没有心臟问题的人有利。与此相一致的是，一些迹象表明它们可以充当情绪稳定剂并帮助那些患有焦虑症或双相情感障碍的人。后者正在接受专门研究，因为与大多数传统的情绪稳定剂或抗精神病药物相比，一些钙通道阻滞剂可能更安全地用于孕妇。因此，这些因素为促进钙通道阻滞剂市场的增长提供了机会。

钙通道阻滞剂市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，全球钙通道阻滞剂市场预计在预测期内（2023-2030）每年将以 6.1% 左右的复合年增长率增长
  • 由于心血管疾病患病率不断上升，钙通道阻滞剂行业预计将大幅增长
  • 根据药物类别细分，预计二氢吡啶将在 2022 年占据最大市场份额
  • 根据应用细分，高血压是预测期内的主要类型
  • 按地区划分，北美是 2022 年的主要收入来源

钙通道阻滞剂市场-細項分析：

  • 全球钙通道阻滞剂市场根据药物类别、应用、分销渠道和地区进行细分。
  • 市场根据药物类别分为三类：二氢吡啶、苯烷基胺和苯并噻嗪。二氢吡啶部分可能拥有最大的收入份额。由于研发活动的增加和製药行业的扩张，预计该细分市场将出现。此外，该药物具有良好的血管选择性以及控制动脉压和血管阻力的能力，在治疗中受到广泛的青睐。二氢吡啶类药物包括非洛地平、氨氯地平、尼群地平和尼莫地平。
  • 根据应用，市场分为四类：心绞痛、高血压、肥厚性心肌病、心律失常等。高血压细分市场预计将占据最大的市场份额。高血压会增加心臟、大脑和肾臟问题的风险。基于此，用于治疗高血压的药物的需求可能会增加。
  • 根据分销渠道，市场分为三类：网上药店、医院药店和零售药店。在预测期内，零售药房领域预计将主导市场。不健康的生活方式导致肥胖和心血管疾病的增加。因此，定期开出此类药物以维持血压。此外，由于市场供应量的增加和高消费，先天性心脏病、心力衰竭、高血压和心脏病等心血管疾病病例的不断增加，也推动了零售药品的扩张。

钙通道阻滞剂市场 - 地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

钙通道阻滞剂市场-竞争格局：

本地和全球公司的存在使得钙通道阻滞剂市场具有适度的竞争性。主要参与者专注于多种增长战略，例如合作、产品发布和收购，这些战略不断促进钙通道阻滞剂在全球的增长。此外，随着世界范围内心血管疾病病例的不断增加，主要参与者正在投入大量资金来开发新的疗法并在市场上维持自己的地位。医疗基础设施的改善正在增加对钙通道阻滞剂的需求。例如，2022年2月，FDA批准了CMP Pharma的Norliqva口服液。此外，该解决方案有助于治疗高血压，降低成人和 6 岁儿童的血压。 Norliqva 采用 150 毫升瓶装，有效期为 36 个月

最近的发展：

例如，2021 年 5 月，生物製药公司 Milestone Pharmaceuticals, Inc. 发布了 Etripamil 3 期 RAPID 临床试验的正面安全性和有效性数据。此外，该公司正在研究钙通道阻滞剂治疗阵发性室上性心动过速（PSVT）的患者。

该研究的主要特点：

  • 这项关于钙通道阻滞剂市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年。
  • 该报告为客户提供了有关钙通道阻滞剂市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了钙通道阻滞剂市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、现有参与者面临的挑战以及钙通道阻滞剂市场维持的增长因素。
  • COVID-19 对钙通道阻滞剂市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将详细介绍新冠疫情后钙通道阻滞剂市场的情况。
  • 为了让本报告的用户全面了解钙通道阻滞剂市场，我们还包括了钙通道阻滞剂市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解钙通道阻滞剂市场参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球钙通道阻滞剂市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

目录

第 1 章：钙通道阻滞剂市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类别分類的钙通道阻滞剂市场片段
    • 钙通道阻滞剂市场片段（按应用）
    • 按分销渠道分類的钙通道阻滞剂市场片段
    • 按国家/地区分類的钙通道阻滞剂市场片段
    • 按地区分類的钙通道阻滞剂市场片段
  • 竞争洞察

第 3 章：钙通道阻滞剂主要市场趋势

  • 钙通道阻滞剂市场驱动因素
    • 市场驱动因素的影响分析
  • 钙通道阻滞剂市场限制
    • 市场限制影响分析
  • 钙通道阻滞剂的市场机会
  • 钙通道阻滞剂市场未来趋势

第 4 章：钙通道阻滞剂行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：钙通道阻滞剂市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：钙通道阻滞剂市场格局

  • 2022 年钙通道阻滞剂市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：钙通道阻滞剂市场 - 按药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 二氢吡啶
    • 苯烷基胺
    • 苯并噻嗪

第 8 章：钙通道阻滞剂市场 -按应用

  • 概述
    • 按应用的细分市场份额分析
    • 心绞痛
    • 高血压
    • 肥厚型心肌病
    • 心律失常
    • 其他的

第 9 章：钙通道阻滞剂市场 - 按分销渠道

  • 概述
    • 按分销渠道分類的细分市场份额分析
    • 网上药店
    • 医院药房
    • 零售药店

第 10 章：钙通道阻滞剂市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 钙通道阻滞剂北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按分销渠道）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 钙通道阻滞剂欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按分销渠道）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 钙通道阻滞剂亚太地区主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模和预测（按应用）
    • 亚太地区市场规模和预测（按分销渠道）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 钙通道阻滞剂拉丁美洲主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按药物类别）
    • 拉丁美洲市场规模和预测（按应用）
    • 拉丁美洲市场规模和预测（按分销渠道）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 钙通道阻滞剂中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按分销渠道）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 钙通道阻滞剂行业

  • 竞争仪表板
  • 公司简介
    • Bayer
    • Sanofi
    • Wyeth-Ayerst
    • ClearSynth
    • AbMole Bioscience
    • Pfizer
    • Lupin Pharmaceuticals, Inc.
    • Searle
    • Knoll Pharmaceuticals
    • GlaxoSmithKline Plc.
    • Aventis
    • AstraZeneca
    • Novartis

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1601

REPORT HIGHLIGHT

Calcium Channel Blockers Market size was valued at USD 14,005.1 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

Calcium channel blockers are known as medications that are utilized to maintain high blood pressure, arrhythmia, and chest pain. Additionally, they can be obtained through prescription and work by relaxing blood vessels and improving the heart's blood and oxygen supply. As a result, this helps to minimize the workload of the heart. Moreover, to treat high blood pressure and angina, it may be prescribed by itself or in conjunction with other medications.

Calcium Channel Blockers Market- Market Dynamics:

  • The increasing prevalence rate of cardiovascular diseases and rising assistance to people with anxiety disorders or bipolar disorder is projected to drive growth in the forecast period.
  • The changing lifestyle of people has resulted in the increasing prevalence rate of cardiovascular diseases is likely to fuel the calcium channel blocker market growth. As these diseases impact the heart or blood vessels and lower the risk of heart failure & stroke, calcium channel blockers are used. Additionally, the major causes associated with heart disease are hypertension, often referred to as elevated blood pressure. The effectiveness of calcium antagonists in curing this indication has been well documented. This in turn, the demand has been growing steadily for this market for improved management of cardiovascular diseases. However, side effects concerning calcium channel blockers including headache, constipation, and edema are expected to hinder the demand for calcium channel blocker market globally. Moreover, calcium channel blockers may be advantageous to a smaller group of persons who do not have heart issues. In line with this, some indications they may act as mood stabilizers and assist those people who suffer from anxiety disorders or bipolar disorder. The latter is specifically under investigation because some calcium channel blockers may be more secure to administer to pregnant women as compared to most traditional mood stabilizers or antipsychotics. Thus, such factors offer opportunity to increase the growth of the calcium channel blocker market.

Calcium Channel Blockers Market- Key Insights:

  • As per the analysis shared by our research analyst, the global calcium channel blocker market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2023-2030)
  • The calcium channel blocker industry is projected to grow at a significant rate due to the increasing prevalence rate of cardiovascular diseases
  • Based on drug class segmentation, dihydropyridine was predicted to show maximum market share in the year 2022
  • Based on application segmentation, hypertension was the leading type over the forecast period
  • On the basis of region, North America was the leading revenue generator in 2022

Calcium Channel Blockers Market- Segmentation Analysis:

  • The global calcium channel blockers market is segmented on the basis of drug class, application, distribution channel, and region.
  • The market is divided into three categories based on drug class: dihydropyridine, phenylalkylamine, and benzothizepine. The dihydropyridine segment is likely to possess the largest revenue share. The segment is anticipated due to the increasing research & development activities and expansion in the pharmaceutical industry. Moreover, the drug has great vascular selectivity and the capacity to control arterial pressure and vascular resistance, which is widely preferred in therapeutics. Dihydropyridine drugs include felodipine, amlodipine, nitrendipine, and nimodipine.
  • The market is divided into four categories based on application: angina, hypertension, hypertrophic cardiomyopathy, arrhythmia, and others. The hypertension segment is expected to hold the largest market share. The hypertension segment raises the risk of heart, brain, and renal problems. Based on this, the demand is likely to increase for drugs used to manage hypertension.
  • The market is divided into three categories based on distribution channels: online pharmacies, hospital pharmacies, and retail pharmacies. The retail pharmacies segment is accounted to dominate the market over the forecast period. The unhealthy lifestyle patterns have been resulting in increasing glowing obesity and cardiovascular diseases. As such drugs are prescribed on a regular basis to maintain the blood pressure. Additionally, rising cases of cardiovascular diseases such as congenital heart disease, heart failure, hypertension, and heart attacks are fueling the expansion of retail medicine owing to increase abundance and high consumption in the market.

Calcium Channel Blockers Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Calcium Channel Blockers Market- Competitive Landscape:

The presence of local and global companies makes the calcium channel blocker market moderately competitive. The major players are focusing on numerous growth strategies such as collaborations, product launches, and acquisitions, which are contributing constantly to the growth of the calcium channel blocker globally. Moreover, with the increasing cases of cardiovascular disease across the world, key players are investing amounts to develop new therapeutics and sustain themselves in the market. The improved healthcare infrastructure is raising the demand for the calcium channel blocker. For instance, in February 2022, FDA approved CMP Pharma's Norliqva oral solution. Additionally, the solution helps to treat hypertension, to lower blood pressure in adults & children 6 years of age. Norliqva comes in 150 mL bottles, which have 36-month dating

Recent Developments:

For instance, in May 2021, Milestone Pharmaceuticals, Inc. a biopharmaceutical company released positive topline safety and efficacy data from the Etripamil Phase 3 RAPID clinical trial. Additionally, the company's investigational calcium channel blocker in patients with paroxysmal supraventricular tachycardia (PSVT).

Key features of the study:

  • This proposed research study on calcium channel blockers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the calcium channel blockers market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for calcium channel blockers market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the calcium channel blockers market.
  • Impact of COVID-19 on calcium channel blockers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on calcium channel blockers market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the calcium channel blockers market, we have also included competitive landscape and key innovator analysis for the calcium channel blockers market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the calcium channel blockers market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global calcium channel blockers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET KEY PLAYERS

  • Bayer
  • Sanofi
  • Wyeth-Ayerst
  • ClearSynth
  • AbMole Bioscience
  • Pfizer
  • Lupin Pharmaceuticals, Inc.
  • Searle
  • Knoll Pharmaceuticals
  • GlaxoSmithKline Plc.
  • Aventis
  • AstraZeneca
  • Novartis

GLOBALCALCIUM CHANNEL BLOCKERS MARKET, BY DRUG CLASS

  • Dihydropyridine
  • Phenylalkylamine
  • Benzothizepine

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY APPLICATION

  • Angina
  • Hypertension
  • Hypertrophic Cardiomyopathy
  • Arrhythmia
  • Others

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY DISTRIBUTION CHANNEL

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies

GLOBAL CALCIUM CHANNEL BLOCKERS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Calcium Channel Blockers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Calcium Channel Blockers Market Snippet by Drug Class
    • 2.1.2. Calcium Channel Blockers Market Snippet by Application
    • 2.1.3. Calcium Channel Blockers Market Snippet by Distribution Channel
    • 2.1.4. Calcium Channel Blockers Market Snippet by Country
    • 2.1.5. Calcium Channel Blockers Market Snippet by Region
  • 2.2. Competitive Insights

3. Calcium Channel Blockers Key Market Trends

  • 3.1. Calcium Channel Blockers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Calcium Channel Blockers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Calcium Channel Blockers Market Opportunities
  • 3.4. Calcium Channel Blockers Market Future Trends

4. Calcium Channel Blockers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Calcium Channel Blockers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Calcium Channel Blockers Market Landscape

  • 6.1. Calcium Channel Blockers Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Calcium Channel Blockers Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Dihydropyridine
    • 7.1.3. Phenylalkylamine
    • 7.1.4. Benzothizepine

8. Calcium Channel Blockers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Angina
    • 8.1.3. Hypertension
    • 8.1.4. Hypertrophic Cardiomyopathy
    • 8.1.5. Arrhythmia
    • 8.1.6. Others

9. Calcium Channel Blockers Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Online Pharmacies
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Retail Pharmacies

10. Calcium Channel Blockers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Calcium Channel Blockers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Calcium Channel Blockers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Calcium Channel Blockers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Calcium Channel Blockers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Calcium Channel Blockers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Calcium Channel Blockers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Bayer
    • 11.2.2. Sanofi
    • 11.2.3. Wyeth-Ayerst
    • 11.2.4. ClearSynth
    • 11.2.5. AbMole Bioscience
    • 11.2.6. Pfizer
    • 11.2.7. Lupin Pharmaceuticals, Inc.
    • 11.2.8. Searle
    • 11.2.9. Knoll Pharmaceuticals
    • 11.2.10. GlaxoSmithKline Plc.
    • 11.2.11. Aventis
    • 11.2.12. AstraZeneca
    • 11.2.13. Novartis

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Calcium Channel Blockers Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Calcium Channel Blockers Market, by Drug Class2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Calcium Channel Blockers Market, by Application2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Calcium Channel Blockers Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Calcium Channel Blockers Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Calcium Channel Blockers Market, by Region 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE EuropeCalcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Calcium Channel Blockers Market, by Distribution Channel, 2018-2030 (USD Million)